Download video

衛福部官官相護成勞部2.0？ 疑「掩護霸凌、縱容性騷」…內幕！ - 黃敬平 張禹宣 凌濤 徐俊相《57爆新聞》20241217-3

No views

57爆新聞

1 day ago

衛福部官官相護成勞部2.0？ 疑「掩護霸凌、縱容性騷」…內幕！ - 黃敬平 張禹宣 凌濤 徐俊相《57爆新聞》20241217-3

衛福部官官相護成勞部2.0？ 疑「掩護霸凌、縱容性騷」…內幕！ - 黃敬平 張禹宣 凌濤 徐俊相《57爆新聞》20241217-3

HEALTHeLINK Guide 2 Better Care: Dr. Lauren Bruckner
1:01
HEALTHeLINK Guide 2 Better Care: Dr. Lauren Bruckner
by HEALTHeLINK
272: How leaders need to rethink their approach to philanthropy
34:38
272: How leaders need to rethink their approach to philanthropy
by Advisory Board
5 Showcasing What is Possible Part 2
28:18
5 Showcasing What is Possible Part 2
by NASEM Health and Medicine Division
Metabolic Dysfunction and the Immune System: Key role of Dendritic Cells as an Immunotherapy
58:16
Metabolic Dysfunction and the Immune System: Key role of Dendritic Cells as an Immunotherapy
by Metabolic Terrain Institute of Health
Reducing Risk - Impact of complaints - Part 2
42:49
Reducing Risk - Impact of complaints - Part 2
by Medical Protection
Newsworthy Numbers: Segment 2
1:03
Newsworthy Numbers: Segment 2
by HometownHealth
Safety and anti-tumor activity of BAY 2927088 in patients with HER2-mutant NSCLC
1:40
Safety and anti-tumor activity of BAY 2927088 in patients with HER2-mutant NSCLC
by VJOncology
Strong Connections #2
0:42
Strong Connections #2
by UR Medicine
COVID-19 Response - Practical measures to manage in a crisis - Chapter 2 - Accessing HMRC support
19:11
COVID-19 Response - Practical measures to manage in a crisis - Chapter 2 - Accessing HMRC support
by Invest Northern Ireland
Newsworthy Numbers: Segment 2
0:58
Newsworthy Numbers: Segment 2
by HometownHealth
Health Report 2\/2\/22
2:36
Health Report 2\/2\/22
by Local 4 News WHBF
WHV Webinar: Dementia Series Part 2: Supporting Caregivers of Veterans with Dementia at End of Life
1:00:43
WHV Webinar: Dementia Series Part 2: Supporting Caregivers of Veterans with Dementia at End of Life
by NHPCO
SH2 Domains as a Target Class in Cancer and Inflammation
30:13
SH2 Domains as a Target Class in Cancer and Inflammation
by Eurofins Discovery
RETAIN-2: Risk-Enabled Therapy After Neoadjuvant Chemo-Immunotherapy for MIBC
8:42
RETAIN-2: Risk-Enabled Therapy After Neoadjuvant Chemo-Immunotherapy for MIBC
by GU Oncology Now
Heads Up pt.2
9:49
Heads Up pt.2
by Alzheimer Society of Saskatchewan
Rise Together 6 21 Pt 2
2:18:24
Rise Together 6 21 Pt 2
by Center for Public Health Workforce Development
Your Will, Your Way, Part 2
24:26
Your Will, Your Way, Part 2
by Major Health Partners
health and wellness2
7:09
health and wellness2
by KPRC 2 Click2Houston
hcsmgbc - session 2 round up (part 2)
15:03
hcsmgbc - session 2 round up (part 2)
by KYOHealth
BEHEALTH 2025 - Panel 2: Mitigating Antimicrobial Resistance
1:29:51
BEHEALTH 2025 - Panel 2: Mitigating Antimicrobial Resistance
by ROHEALTH-Cluster
Innovation 2
1:00:48
Innovation 2
by NationalHRDNetwork